| Geographical Segments | Interventional cardiology devices, structural heart therapy products, peripheral vascular intervention devices. | Strong IP in stent technology, exclusive distribution partnerships, and established global clinical evidence. | Primarily B2B - hospitals, clinics, healthcare providers across 69+ countries. | Structural heart therapy and coronary stents deliver highest margins. | 1025 | 85 | Product sales through direct and distributor channels globally. | Market-appropriate pricing supported by strong clinical data and quality assurance. | Global market expansion, new product launches, and increased adoption in developed and emerging healthcare markets. | Supraflex Cruz, Renofit |
| Domestic India | Vascular devices tailored for Indian healthcare needs. | Local manufacturing facilities enabling cost advantages and quick supply chain. | Hospitals and healthcare providers in India. | Interventional cardiology devices. | 320 | 15 | Direct sales and hospital partnerships in India. | Competitive pricing to maximize accessibility and volume. | Rising cardiovascular disease burden in India and growing healthcare infrastructure investments. | Supraflex Cruz, Renofit |
